Skip to main content

Table 5 Patient outcomes

From: Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal

 

PCC3 (n = 74)

LD rFVIIa (n = 32)

p

Mortality, n (%)

22 (29.7%)

6 (18.8%)

0.34

LOS all pts (d)*

8.0 [4-11]

7.5 [5-13]

0.43

LOS survivors (d)*

8.0 [4-11]

9.5 [6-13]

0.15

Thromboembolic events

5

2

1.00

DVT

2

2

 

IJ thrombus

1

0

 

Multiple CVA’s

1

0

 

Chest tube clots

1

0

 

(and possible unconfirmed CVA)

  1. *Data as median [IQR].
  2. PCC3, 3 factor prothrombin complex concentrate; LDrFVIIa, low dose recombinant factor VII activated; LOS, length of stay; DVT, deep vein thrombosis, IJ, internal jugular; CVA, cerebral vascular accident.
Back to article page

World Journal of Emergency Surgery

ISSN: 1749-7922